Tabula Rasa HealthCare (TRHC) Misses Q2 EPS

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q2 EPS of ($0.53) from continuing operations, $0.32 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $68.31 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c